Neogen Corporation (NEOG) financial statements (2021 and earlier)

Company profile

Business Address 620 LESHER PLACE
LANSING, MI 48912
State of Incorp. MI
Fiscal Year End May 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

2/28/2021
Q3
11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
2/29/2020
Q3
11/30/2019
Q2
8/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments353391367344328314291
Cash and cash equivalents731146166516656
Short-term investments280277307277277247235
Receivables87807885818579
Inventory, net of allowances, customer advances and progress billings99939895898688
Inventory99939895898688
Other undisclosed current assets15151414171516
Total current assets:555578557537515500474
Noncurrent Assets
Operating lease, right-of-use asset122    
Property, plant and equipment98848179787775
Intangible assets, net (including goodwill)226182183 180173172
Goodwill133112112 110104103
Intangible assets, net (excluding goodwill)937071 707070
Other noncurrent assets   181   
Total noncurrent assets:325267265260259250248
TOTAL ASSETS:880846822797774751721
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46454648393940
Accounts payable23212326192018
Accrued liabilities15151414131313
Employee-related liabilities8868665
Taxes payable 051114
Total current liabilities:46454648393940
Noncurrent Liabilities
Long-term debt and lease obligation   1111
Operating lease, liability   1111
Liabilities, other than long-term debt2724245655
Deferred income tax liabilities211818    
Other liabilities5555655
Other undisclosed noncurrent liabilities   17151415
Total noncurrent liabilities:27242424222120
Total liabilities:73687072626061
Stockholders' equity
Stockholders' equity attributable to parent808777752725712691660
Common stock9988888
Additional paid in capital290273264258255244232
Accumulated other comprehensive loss(15)(15)(16)(20)(14)(12)(14)
Retained earnings524510495479462450434
Total stockholders' equity:808777752725712691660
TOTAL LIABILITIES AND EQUITY:880846822797774751721

Income statement (P&L) ($ in millions)

2/28/2021
Q3
11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
2/29/2020
Q3
11/30/2019
Q2
8/31/2019
Q1
Revenues117115109109100108101
Cost of revenue
(Cost of Goods and Services Sold)
(63)(62)(59)(57)(55)(57)(53)
Gross profit:54535052455148
Operating expenses(38)(34)(31)(32)(32)(33)(32)
Operating income:16191920131816
Nonoperating income0011111
Other nonoperating income (expense)(0)(0)0(0)(0)(0)(0)
Income from continuing operations before income taxes:16192021141918
Income tax expense(3)(3)(4)(5)(2)(3)(3)
Net income available to common stockholders, diluted:13161616121615

Comprehensive Income ($ in millions)

2/28/2021
Q3
11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
2/29/2020
Q3
11/30/2019
Q2
8/31/2019
Q1
Net income:13161616121615
Other comprehensive income (loss)014 (2)2(2)
Other undisclosed comprehensive loss   (8)   
Comprehensive income:1417208111812
Other undisclosed comprehensive income, net of tax, attributable to parent   2   
Comprehensive income, net of tax, attributable to parent:14172010111812

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: